Intrinsic Value of S&P & Nasdaq Contact Us

argenx SE ARGX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • NL • USD

SharesGrow Score
80/100
5/7 Pass
SharesGrow Intrinsic Value
$973.18
+17.5%
Analyst Price Target
$1,026.71
+23.9%

Financial Health Score — ARGX

argenx SE (ARGX) has an overall financial health rating of B+ with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2026-04-07.

B+
Overall Rating
2026-04-07

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2026-04-07 B+ -/5 -/5 -/5 -/5 -/5 -/5
2026-04-06 B+ -/5 -/5 -/5 -/5 -/5 -/5
2026-04-02 B+ -/5 -/5 -/5 -/5 -/5 -/5
2026-04-01 B+ -/5 -/5 -/5 -/5 -/5 -/5
2026-03-31 A- -/5 -/5 -/5 -/5 -/5 -/5
2026-03-30 A- -/5 -/5 -/5 -/5 -/5 -/5
2026-03-27 A- -/5 -/5 -/5 -/5 -/5 -/5
2026-03-26 A- -/5 -/5 -/5 -/5 -/5 -/5
2026-03-25 A- -/5 -/5 -/5 -/5 -/5 -/5
2026-03-24 A- -/5 -/5 -/5 -/5 -/5 -/5
2026-03-23 A- -/5 -/5 -/5 -/5 -/5 -/5
2026-03-20 A- -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message